150 related articles for article (PubMed ID: 31718049)
1. Mutation S115T in IMP-Type Metallo-β-Lactamases Compensates for Decreased Expression Levels Caused by Mutation S119G.
Zhang CJ; Faheem M; Dang P; Morris MN; Kumar P; Oelschlaeger P
Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31718049
[TBL] [Abstract][Full Text] [Related]
2. Elucidating the Role of Residue 67 in IMP-Type Metallo-β-Lactamase Evolution.
LaCuran AE; Pegg KM; Liu EM; Bethel CR; Ai N; Welsh WJ; Bonomo RA; Oelschlaeger P
Antimicrob Agents Chemother; 2015 Dec; 59(12):7299-307. PubMed ID: 26369960
[TBL] [Abstract][Full Text] [Related]
3. Insight into stereochemistry of a new IMP allelic variant (IMP-55) metallo-β-lactamase identified in a clinical strain of Acinetobacter baumannii.
Shakibaie MR; Azizi O; Shahcheraghi F
Infect Genet Evol; 2017 Jul; 51():118-126. PubMed ID: 28336429
[TBL] [Abstract][Full Text] [Related]
4. Understanding the determinants of substrate specificity in IMP family metallo-β-lactamases: the importance of residue 262.
Pegg KM; Liu EM; George AC; LaCuran AE; Bethel CR; Bonomo RA; Oelschlaeger P
Protein Sci; 2014 Oct; 23(10):1451-60. PubMed ID: 25131397
[TBL] [Abstract][Full Text] [Related]
5. An in silico approach for understanding the molecular evolution of clinically important metallo-beta-lactamases.
Pal A; Tripathi A
Infect Genet Evol; 2013 Dec; 20():39-47. PubMed ID: 23954421
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the functional contributions of Asn233 in metallo-β-lactamase IMP-1.
Brown NG; Horton LB; Huang W; Vongpunsawad S; Palzkill T
Antimicrob Agents Chemother; 2011 Dec; 55(12):5696-702. PubMed ID: 21896903
[TBL] [Abstract][Full Text] [Related]
7. Description of IMP-31, a novel metallo-β-lactamase found in an ST235 Pseudomonas aeruginosa strain in Western Germany.
Pfennigwerth N; Geis G; Gatermann SG; Kaase M
J Antimicrob Chemother; 2015 Jul; 70(7):1973-80. PubMed ID: 25835992
[TBL] [Abstract][Full Text] [Related]
8. Carbapenem Use Is Driving the Evolution of Imipenemase 1 Variants.
Cheng Z; Bethel CR; Thomas PW; Shurina BA; Alao JP; Thomas CA; Yang K; Marshall SH; Zhang H; Sturgill AM; Kravats AN; Page RC; Fast W; Bonomo RA; Crowder MW
Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468463
[TBL] [Abstract][Full Text] [Related]
9. Modeling domino effects in enzymes: molecular basis of the substrate specificity of the bacterial metallo-beta-lactamases IMP-1 and IMP-6.
Oelschlaeger P; Schmid RD; Pleiss J
Biochemistry; 2003 Aug; 42(30):8945-56. PubMed ID: 12885227
[TBL] [Abstract][Full Text] [Related]
10. Hydroxyl groups in the betabeta sandwich of metallo-beta-lactamases favor enzyme activity: Tyr218 and Ser262 pull down the lid.
Oelschlaeger P; Pleiss J
J Mol Biol; 2007 Feb; 366(1):316-29. PubMed ID: 17157873
[TBL] [Abstract][Full Text] [Related]
11. The sequence-activity relationship between metallo-β-lactamases IMP-1, IMP-6, and IMP-25 suggests an evolutionary adaptation to meropenem exposure.
Liu EM; Pegg KM; Oelschlaeger P
Antimicrob Agents Chemother; 2012 Dec; 56(12):6403-6. PubMed ID: 23006757
[TBL] [Abstract][Full Text] [Related]
12. Structural insights into the substrate specificity of IMP-6 and IMP-1 metallo-β-lactamases.
Yamamoto K; Tanaka H; Kurisu G; Nakano R; Yano H; Sakai H
J Biochem; 2022 Dec; 173(1):21-30. PubMed ID: 36174533
[TBL] [Abstract][Full Text] [Related]
13. IMP-68, a Novel IMP-Type Metallo-β-Lactamase in Imipenem-Susceptible Klebsiella pneumoniae.
Kubota H; Suzuki Y; Okuno R; Uchitani Y; Ariyoshi T; Takemura N; Mihara F; Mezaki K; Ohmagari N; Matsui M; Suzuki S; Sekizuka T; Kuroda M; Yokoyama K; Sadamasu K
mSphere; 2019 Oct; 4(5):. PubMed ID: 31666316
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of VIM-2 reveals an essential determinant for metallo-beta-lactamase stability and folding.
Borgianni L; Vandenameele J; Matagne A; Bini L; Bonomo RA; Frère JM; Rossolini GM; Docquier JD
Antimicrob Agents Chemother; 2010 Aug; 54(8):3197-204. PubMed ID: 20498317
[TBL] [Abstract][Full Text] [Related]
15. Potency of IMP-10 metallo-beta-lactamase in hydrolysing various antipseudomonal beta-lactams.
Zhao WH; Hu ZQ; Shimamura T
J Med Microbiol; 2008 Aug; 57(Pt 8):974-979. PubMed ID: 18628498
[TBL] [Abstract][Full Text] [Related]
16. His224 alters the R2 drug binding site and Phe218 influences the catalytic efficiency of the metallo-β-lactamase VIM-7.
Leiros HK; Skagseth S; Edvardsen KS; Lorentzen MS; Bjerga GE; Leiros I; Samuelsen Ø
Antimicrob Agents Chemother; 2014 Aug; 58(8):4826-36. PubMed ID: 24913158
[TBL] [Abstract][Full Text] [Related]
17. [Structure-Function Analysis and Development of Inhibitors of Metallo-β-lactamases Conferring Drug Resistance in Bacteria].
Yamaguchi Y
Yakugaku Zasshi; 2015; 135(11):1299-305. PubMed ID: 26521879
[TBL] [Abstract][Full Text] [Related]
18. Metallo-beta-lactamases of Pseudomonas aeruginosa--a novel mechanism resistance to beta-lactam antibiotics.
Sacha P; Wieczorek P; Hauschild T; Zórawski M; Olszańska D; Tryniszewska E
Folia Histochem Cytobiol; 2008; 46(2):137-42. PubMed ID: 18519228
[TBL] [Abstract][Full Text] [Related]
19. Amino acid changes at the VIM-48 C-terminus result in increased carbapenem resistance, enzyme activity and protein stability.
Liu Z; Zhang R; Li W; Yang L; Liu D; Wang S; Shen J; Wang Y
J Antimicrob Chemother; 2019 Apr; 74(4):885-893. PubMed ID: 30590504
[TBL] [Abstract][Full Text] [Related]
20. Hydroxyl groups in the (beta)beta sandwich of metallo-beta-lactamases favor enzyme activity: a computational protein design study.
Oelschlaeger P; Mayo SL
J Mol Biol; 2005 Jul; 350(3):395-401. PubMed ID: 15946681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
